Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amadeu, Pelegrí"'
Autor:
Miguel, Martín, Alvaro, Rodríguez-Lescure, Amparo, Ruiz, Emilio, Alba, Lourdes, Calvo, Manuel, Ruiz-Borrego, Blanca, Munárriz, César A, Rodríguez, Carmen, Crespo, Enrique, de Alava, José Antonio, López García-Asenjo, María Dolores, Guitián, Sergio, Almenar, Jesús Fernando, González-Palacios, Francisco, Vera, José, Palacios, Manuel, Ramos, Jose Manuel, Gracia Marco, Ana, Lluch, Isabel, Alvarez, Miguel Angel, Seguí, José Ignacio, Mayordomo, Antonio, Antón, José Manuel, Baena, Arrate, Plazaola, Alfonso, Modolell, Amadeu, Pelegrí, Jose Ramón, Mel, Enrique, Aranda, Encarna, Adrover, José Valero, Alvarez, José Luis, García Puche, Pedro, Sánchez-Rovira, Sonia, Gonzalez, José Manuel, López-Vega, M Francisca, Garijo
Publikováno v:
JNCI Journal of the National Cancer Institute. 100:805-814
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; BACKGROUND Taxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a consequence, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231d70f647e63977f91a08e2c0626e55
https://doi.org/10.1093/jnci/djn151
https://doi.org/10.1093/jnci/djn151
Autor:
Eva Carrasco, Marta Martı́n-Richard, Javier Virizuela, A. Arcusa, Antonio Antón, J. Florián, Amadeu Pelegrí, Jose I. Mayordomo, Santiago Vázquez, Lourdes Calvo, José L. Bayo
Publikováno v:
Clinical Breast Cancer. 6:433-438
Background The purpose of this study was to assess the toxicity and efficacy of the combination of docetaxel and gemcitabine every 2 weeks as first-line therapy in metastatic breast cancer. Patients and Methods We selected patients between the ages o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ecac917bb9dd2adfbc5ec25b42f0604
https://doi.org/10.3816/cbc.2005.n.048
https://doi.org/10.3816/cbc.2005.n.048
Autor:
José Luis García-Puche, Ana María Lozano, Amadeu Pelegrí, Enrique Aranda, Ana Balil, A. Oltra, Antonio Casado, Ramón Pérez-Carrión, Eduardo Díaz-Rubio, María Dolores Menéndez, María del Carmen Talavera, Emilio Alba, Álvaro Rodríguez-Lescure, José Antonio Virizuela, Miguel Martin, Javier Casinello
Publikováno v:
Scopus-Elsevier
Purpose. To determine the efficacy of high-dose consolidation DICEP chemotherapy (HD-DICEP) in prolonging progression free survival (PFS) of chemotherapy-responsive metastatic breast cancer (MBC) patients with monotopic disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bab30858680973d27b18ec319ec131
https://doi.org/10.1007/bf02712849
https://doi.org/10.1007/bf02712849
Autor:
Agustí Barnadas, Carlos Jara-Sanchez, Miguel Martin, J. M. López-Vega, Antonio Fernández-Aramburo, José A. García-Sáenz, Antonio Casado, Emilio Alba, Amadeu Pelegrí
Publikováno v:
Clinical Breast Cancer. 3:399-404
The efficacy of vinorelbine given as a continuous infusion was evaluated in 47 patients with breast cancer who had received previous treatment with first-line, second-line, and third-line chemotherapy including taxanes and/or anthracyclines. For incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8fa7971182ec60fc91559d153dfef87
https://doi.org/10.3816/cbc.2003.n.004
https://doi.org/10.3816/cbc.2003.n.004
Autor:
N. Bosch, Miriam Masas, Amadeu Pelegrí, Orland Diez, Anna Tenés, Sara Gutiérrez-Enríquez, Begoña Graña, Judith Balmaña, Neus Gadea
Limited information exists regarding BRCA1 and BRCA2 genetic testing and genetic diversity in BRCA1 and BRCA2 in sub-Saharan African populations. We report a novel mutation that consists of a deletion of 2 bp (c.1949_1950delTA) in the exon 11 of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fcc1ba5cde9d17d2bf36149ff8d7d9b
https://europepmc.org/articles/PMC3406549/
https://europepmc.org/articles/PMC3406549/
Autor:
Antonio Antón, J. Florián, Marta Martı́n-Richard, Lourdes Calvo, José L. Bayo, A. Arcusa, Amadeu Pelegrí, Santiago Vázquez, Jose I. Mayordomo, Eva Carrasco, Javier Virizuela
Publikováno v:
Seminars in oncology. 31(2 Suppl 5)
The purpose of this study was to assess the toxicity and efficacy of gemcitabine and docetaxel administered every other week as first-line therapy in metastatic breast cancer. Fifty-one patients with histologically confirmed metastatic breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4ee2a9712f320144ceef5ea6f4984c
https://pubmed.ncbi.nlm.nih.gov/15199528
https://pubmed.ncbi.nlm.nih.gov/15199528